• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Thailand·Healthcare·PR9.BK
Share

Praram 9 Hospital Public Company Limited Stocks

THB 16.3Last Updated 12.06.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

THB 388.86M

THB 16.3
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of PR9.BK is 25 and suggests 51% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

13.06.2026 16:01

Small caps last week: Record biotech IPO, Wizz Air's solid top line, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026